<

INVENTIVA (EPA:IVA) Inventiva announces that its partner Sino Biopharm received IND approval from the NMPA to initiate clinical trial with lanifibranor in China

Transparency directive : regulatory news

25/05/2023 22:00



Other stories

20/04/2024 16:37
20/04/2024 19:55
20/04/2024 18:50
20/04/2024 05:33
20/04/2024 15:31
20/04/2024 14:35
20/04/2024 18:34
20/04/2024 13:27
20/04/2024 12:14
20/04/2024 10:39
20/04/2024 13:27
20/04/2024 11:25
19/04/2024 19:17
20/04/2024 14:03
20/04/2024 02:44
20/04/2024 13:57
20/04/2024 14:08
20/04/2024 12:58
20/04/2024 08:37
20/04/2024 05:35
20/04/2024 19:00
20/04/2024 17:36
20/04/2024 07:00
20/04/2024 10:45
20/04/2024 18:15
20/04/2024 18:16
20/04/2024 18:13
20/04/2024 12:30
20/04/2024 10:29
20/04/2024 09:37
19/04/2024 21:18
19/04/2024 12:40
20/04/2024 10:22
20/04/2024 19:00
20/04/2024 08:56
20/04/2024 10:53